Dec 23, 2021 · The present first-in-human trial aims to explore the safety and, in part, the efficacy of a transendocardial injection of autologous VCF in ...
Jul 14, 2021 · To deliver the cell therapy, MTC001 will include a minimally invasive cell administration injection catheter, primarily developed by JLL. The ...
Dec 23, 2021 · This clinical trial aims to explore the safety and, in part, the efficacy of autologous VCF therapy for chronic ischemic HF. Methods: : This ...
May 3, 2024 · MTC-001 is under development for the treatment of chronic ischemic heart failure. The drug candidate constitutes of VCAM-1-positive cardiac ...
Apr 4, 2022 · Metcela's lead asset, MTC001, is a combination product of autologous VCAM-1-positive cardiac fibroblasts (“VCF”) and a precision delivery device ...
Jun 24, 2020 · Under the business alliance agreement, the Company and Metcela aim for an early completion of clinical trials and commercialization of “MTC001”, ...
Phase I study of MTC001 in patients with chronic ischemic heart failure
rctportal.niph.go.jp › detail
Jul 25, 2022 · 1)Patients diagnosed with heart failure with old myocardial infarction as the underlying disease. 2)Patients with chronic ischemic heart failure ...
$4.50 7-day returns
11/0 brass metal seed bead. Current manufacture from the USA. 10 grams per package, approximately 520 beads. Uniformly sized, great for peyote stitch and ...